These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 37242499)
1. Design, Synthesis, and Anti-Proliferative Action of Purine/Pteridine-Based Derivatives as Dual Inhibitors of EGFR and BRAF El-Kalyoubi SA; Gomaa HAM; Abdelhafez EMN; Ramadan M; Agili F; Youssif BGM Pharmaceuticals (Basel); 2023 May; 16(5):. PubMed ID: 37242499 [TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of Indole-2-carboxamides as Potential Multi-Target Antiproliferative Agents. Al-Wahaibi LH; Mohammed AF; Abdelrahman MH; Trembleau L; Youssif BGM Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513950 [TBL] [Abstract][Full Text] [Related]
3. Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAF Gomaa HAM; Shaker ME; Alzarea SI; Hendawy OM; Mohamed FAM; Gouda AM; Ali AT; Morcoss MM; Abdelrahman MH; Trembleau L; Youssif BGM Bioorg Chem; 2022 Mar; 120():105616. PubMed ID: 35078049 [TBL] [Abstract][Full Text] [Related]
4. Synthesis of a new series of 4-pyrazolylquinolinones with apoptotic antiproliferative effects as dual EGFR/BRAF Al-Wahaibi LH; Youssif BGM; Abou-Zied HA; Bräse S; Brown AB; Tawfeek HN; El-Sheref EM RSC Med Chem; 2024 Jul; 15(7):2538-2552. PubMed ID: 39026636 [TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Antiproliferative Activity of New 5-Chloro-indole-2-carboxylate and Pyrrolo[3,4- Al-Wahaibi LH; Mohammed AF; Abdelrahman MH; Trembleau L; Youssif BGM Molecules; 2023 Jan; 28(3):. PubMed ID: 36770936 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and Structure Determination of Substituted Thiazole Derivatives as EGFR/BRAF Al-Wahaibi LH; El-Sheref EM; Hassan AA; Bräse S; Nieger M; Youssif BGM; Ibrahim MAA; Tawfeek HN Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513926 [TBL] [Abstract][Full Text] [Related]
7. Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAF Abou-Zied HA; Beshr EAM; Gomaa HAM; Mostafa YA; Youssif BGM; Hayallah AM; Abdel-Aziz M Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200464. PubMed ID: 36526595 [TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as antiproliferative EGFR and BRAF Al-Wahaibi LH; Gouda AM; Abou-Ghadir OF; Salem OIA; Ali AT; Farghaly HS; Abdelrahman MH; Trembleau L; Abdu-Allah HHM; Youssif BGM Bioorg Chem; 2020 Nov; 104():104260. PubMed ID: 32920363 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of new thiazolidinone/uracil derivatives as antiproliferative agents targeting EGFR and/or BRAF Alshammari MB; Aly AA; Youssif BGM; Bräse S; Ahmad A; Brown AB; Ibrahim MAA; Mohamed AH Front Chem; 2022; 10():1076383. PubMed ID: 36578355 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, biological evaluation, and docking studies of novel (imidazol-5-yl)pyrimidine-based derivatives as dual BRAF Ali EMH; El-Telbany RFA; Abdel-Maksoud MS; Ammar UM; Mersal KI; Zaraei SO; El-Gamal MI; Choi SI; Lee KT; Kim HK; Lee KH; Oh CH Eur J Med Chem; 2021 Apr; 215():113277. PubMed ID: 33601311 [TBL] [Abstract][Full Text] [Related]
11. Design, Synthesis, Antiproliferative Actions, and DFT Studies of New Bis-Pyrazoline Derivatives as Dual EGFR/BRAF Al-Wahaibi LH; Abou-Zied HA; Beshr EAM; Youssif BGM; Hayallah AM; Abdel-Aziz M Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240450 [TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAF Al-Wahaibi LH; Abou-Zied HA; Hisham M; Beshr EAM; Youssif BGM; Bräse S; Hayallah AM; Abdel-Aziz M Molecules; 2023 Sep; 28(18):. PubMed ID: 37764362 [TBL] [Abstract][Full Text] [Related]
13. Quinazolin-4-one/3-cyanopyridin-2-one Hybrids as Dual Inhibitors of EGFR and BRAF Al-Wahaibi LH; Hisham M; Abou-Zied HA; Hassan HA; Youssif BGM; Bräse S; Hayallah AM; Abdel-Aziz M Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004388 [TBL] [Abstract][Full Text] [Related]
14. One-Pot Synthesis of 1-Thia-4-azaspiro[4.4/5]alkan-3-ones via Schiff Base: Design, Synthesis, and Apoptotic Antiproliferative Properties of Dual EGFR/BRAF Al-Wahaibi LH; El-Sheref EM; Hammouda MM; Youssif BGM Pharmaceuticals (Basel); 2023 Mar; 16(3):. PubMed ID: 36986566 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRAF Wang Y; Wan S; Li Z; Fu Y; Wang G; Zhang J; Wu X Eur J Med Chem; 2018 Jul; 155():210-228. PubMed ID: 29886324 [TBL] [Abstract][Full Text] [Related]
16. Efficient Synthesis and Biological Evaluation of 6-Trifluoroethoxy Functionalized Pteridine Derivatives as EGFR Inhibitors. Lin J; Zhang Z; Lin X; Chen Z; Luc T; Zha D; Wang J; Xu X; Li Z Med Chem; 2022; 18(3):353-363. PubMed ID: 34097593 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and biological evaluation of novel imidazole derivatives possessing terminal sulphonamides as potential BRAF Ali EMH; Abdel-Maksoud MS; Ammar UM; Mersal KI; Ho Yoo K; Jooryeong P; Oh CH Bioorg Chem; 2021 Jan; 106():104508. PubMed ID: 33280830 [TBL] [Abstract][Full Text] [Related]
18. Benzimidazole-Based Derivatives as Apoptotic Antiproliferative Agents: Design, Synthesis, Docking, and Mechanistic Studies. Youssif BGM; Morcoss MM; Bräse S; Abdel-Aziz M; Abdel-Rahman HM; Abou El-Ella DA; Abdelhafez ESMN Molecules; 2024 Jan; 29(2):. PubMed ID: 38257358 [TBL] [Abstract][Full Text] [Related]
19. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights. Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598 [TBL] [Abstract][Full Text] [Related]
20. Novel antiproliferative agents bearing substituted thieno[2,3-d]pyrimidine scaffold as dual VEGFR-2 and BRAF kinases inhibitors and apoptosis inducers; design, synthesis and molecular docking. Hassan RA; Hamed MIA; Abdou AM; El-Dash Y Bioorg Chem; 2022 Aug; 125():105861. PubMed ID: 35569190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]